Abstract

African swine fever (ASF) was introduced into the Eastern European Union in 2014 and led to considerable mortality among wild boar. In contrast, unexpected high antibody prevalence was reported in hunted wild boar in north-eastern Estonia. One of the causative virus strains was recently characterized. While it still showed rather high virulence in the majority of experimentally infected animals, one animal survived and recovered completely. Here, we report on the follow-up characterization of the isolate obtained from the survivor in the acute phase of infection. As a first step, three in vivo experiments were performed with different types of pigs: twelve minipigs (trial A), five domestic pigs (trial B), and five wild boar (trial C) were inoculated. 75% of the minipigs and all domestic pigs recovered after an acute course of disease. However, all wild boar succumbed to infection within 17 days. Representative samples were sequenced using NGS-technologies, and whole-genomes were compared to ASFV “Georgia 2007/1”. The alignments indicated a deletion of 14560 base pairs at the 5’ end, and genome reorganization by duplication. The characteristic deletion was confirmed in all trial samples and local field samples. In conclusion, an ASFV variant was found in Estonia that showed reduced virulence.

Highlights

  • In 2014, African swine fever virus (ASFV) was introduced into Poland and the Baltic European Union (EU) member states Latvia, Lithuania and Estonia

  • Compared to what is so far known about the virulence of ASFV genotype II in both domestic pigs and European wild boar under experimental conditions[3,4,5,6,7], the north-eastern Estonian strain re-isolated from a surviving animal during acute infection showed a clearly attenuated phenotype in trials A and B

  • The use of minipigs with potbelly pig ancestry for ASF trials with blood sampling has to be reassessed for animal welfare reasons

Read more

Summary

Introduction

In 2014, African swine fever virus (ASFV) was introduced into Poland and the Baltic European Union (EU) member states Latvia, Lithuania and Estonia. In the follow-up of those observations, we recently reported an animal experiment that aimed at the biological characterization of an ASFV strain from north-eastern Estonia, where an unexpectedly high ASFV-antibody prevalence was found in hunted healthy animals[2] In this previous animal trial, ten wild boar were inoculated with the above mentioned ASFV strain to evaluate if the clinical course of the disease differed from infections with the so far known highly virulent Caucasian strains[3,4,5,6]. The virus showed still considerable virulence and lethality, but one animal recovered and could represent one of the antibody positive wild boar found in the hunting bags of north-eastern Estonia These results left us with several unanswered questions, including: Is the survival of one animal within the normal range of clinical courses of a highly virulent ASFV strain or is it an indication for true attenuation? In order to confirm the circulation of the variant strain, Estonian field samples were screened for the mentioned mutation by real-time quantitative polymerase chain reaction (qPCR)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call